Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

SAB Biotherapeutics Posts Q2 2026 Net Loss of $22.5 Million

SAB Biotherapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, disclosing a net loss of $22.491 million for the second quarter and $41.360 million for the first half of the year, alongside a significant expansion of its …

Nitish Kishor | 06 August 2026

Lantheus Holdings Reports Q2 2026 Financial Results

Lantheus Holdings, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 6, 2026, covering the quarterly period ended June 30, 2026.

Nitish Kishor | 06 August 2026

Acadian Asset Management Q2 2026 Quarterly Results

Acadian Asset Management Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 6, 2026, reporting financial results for the three and six months ended June 30, 2026.

Manish Choudhary | 06 August 2026

Sabre Corporation Reports Q2 2026 Financial Results

Sabre Corporation filed its quarterly report on Form 10-Q with the SEC on August 6, 2026, covering the three and six months ended June 30, 2026, disclosing revenue growth alongside a continued net loss position for the period.

Aakashdeep | 06 August 2026

BlackRock TCP Capital Sells 95% of Continuation Vehicle for $152 Million

BlackRock TCP Capital Corp. filed a Form 8-K on August 6, 2026, disclosing that it closed a transaction on August 4, 2026, selling 95% of the limited liability company interests in BlackRock DLF-C 2026, LLC to investment funds and accounts managed by Pantheon Ventures …

Anjali Anand | 06 August 2026

BlackRock TCP Capital Corp. Reports Q2 2026 Results

BlackRock TCP Capital Corp. filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting a net decrease in net assets from operations of $14,552,100 for the six months ended June 30, 2026, compared with a net increase of $4,988,004 for the …

Aakashdeep | 06 August 2026

Ecolab Posts Q2 2026 Net Sales of $4.42 Billion

Ecolab Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 6, 2026, reporting second-quarter and first-half financial results for the period.

Anjali Anand | 06 August 2026

MBX Biosciences Reports Q2 2026 Results and Clinical Update

MBX Biosciences, Inc. filed a Current Report on Form 8-K on August 6, 2026, announcing its financial results for the quarter ended June 30, 2026, providing a clinical trial update for its lead candidate MBX 4291, and furnishing an updated corporate presentation under Regulation …

Aditi Sarkar | 06 August 2026

Edgewise Therapeutics Files Q2 2026 Form 10-Q

Edgewise Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, as reported on August 6, 2026.

Anjali Anand | 06 August 2026

Patrick Industries Reports Q2 2026 Financial Results

Patrick Industries, Inc. filed its quarterly report on Form 10-Q with the SEC on August 6, 2026, covering the fiscal quarter ended June 28, 2026, reporting net income of $43.4 million on net sales of approximately $1.04 billion.

Shwetambri Chauhan | 06 August 2026
Support

Hi! How can we help you today?

Loading…